LIPOPROTEIN ALTERATIONS AND PLASMA-LIPOPROTEIN LIPASE REDUCTION IN FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

被引:38
|
作者
HENTER, JI
CARLSON, LA
SODER, O
NILSSONEHLE, P
ELINDER, G
机构
[1] KAROLINSKA INST,SACHS CHILDRENS HOSP,S-10401 STOCKHOLM 60,SWEDEN
[2] KAROLINSKA INST,KING GUSTAF V RES INST,S-10401 STOCKHOLM 60,SWEDEN
[3] UNIV LUND,DEPT CLIN CHEM,S-22101 LUND,SWEDEN
来源
ACTA PAEDIATRICA SCANDINAVICA | 1991年 / 80卷 / 6-7期
关键词
FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HYPERLIPIDEMIA; LIPOPROTEIN LIPASE; CYTOKINES;
D O I
10.1111/j.1651-2227.1991.tb11928.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Serum lipid abnormalities are common in familial hemophagocytic lymphohistocytosis (FHL), a disorder also characterized by fever, hepatosplenomegaly, pancytopenia and a prominent lymphohistiocytic accumulation in the mononuclear phagocyte system. The lipoprotein pattern in nine children with FHL was studied with a quantitative method measuring cholesterol and triglycerides in each major class of lipoproteins. Triglycerides were markedly elevated during active FHL in serum, very low density lipoproteins, and low density lipoproteins. Cholesterol was increased in very low density lipoproteins whereas both triglycerides and cholesterol were extremely low in high density lipoproteins. These lipoprotein abnormalities, reversible on successful therapy, are compatible with a depressed lipolytic activity. Post-heparin levels of lipoprotein lipase and hepatic lipase in plasma were studied in four children and found to be markedly low during active FHL. We suggest that inflammatory cytokines, which may strongly suppress lipoprotein lipase activity, can be important mediators in the pathophysiology of FHL and that they may participate in the development of the lipid abnormalities.
引用
收藏
页码:675 / 681
页数:7
相关论文
共 50 条
  • [1] POSTHEPARIN PLASMA-LIPOPROTEIN LIPASE ACTIVITY IN HETEROZYGOTES OF FAMILIAL LIPOPROTEIN-LIPASE DEFICIENCY
    KONDO, Y
    KUROBANE, I
    OMURA, K
    SANO, R
    ABE, R
    CHIDA, N
    TADA, K
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 145 (01): : 1 - 6
  • [2] PLASMA-LIPOPROTEIN ALTERATIONS IN THYROID-DYSFUNCTION - ROLES OF LIPOPROTEIN-LIPASE, HEPATIC LIPASE AND LCAT
    VALDEMARSSON, S
    ACTA ENDOCRINOLOGICA, 1983, 103 : 1 - 52
  • [3] LIPOPROTEIN-LIPASE AND HEPATIC ENDOTHELIAL LIPASE - THEIR ROLES IN PLASMA-LIPOPROTEIN METABOLISM
    KINNUNEN, PKJ
    VIRTANEN, JA
    VAINIO, P
    ATHEROSCLEROSIS REVIEWS, 1983, 11 : 65 - 105
  • [4] FUNCTION OF HEPATIC LIPASE ON PLASMA-LIPOPROTEIN METABOLISM
    GRETEN, H
    GROSSER, J
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1980, 10 (02) : 14 - 14
  • [5] HUMAN POSTHEPARIN PLASMA-LIPOPROTEIN LIPASE AND HEPATIC TRIGLYCERIDE LIPASE
    JACKSON, RL
    MCLEAN, LR
    METHODS IN ENZYMOLOGY, 1991, 197 : 339 - 345
  • [6] PLASMA-LIPOPROTEIN LIPASE AND HEPATIC LIPASE ACTIVITIES IN FRIEDREICHS ATAXIA
    BLACHE, D
    BOUTHILLIER, D
    BARBEAU, A
    DAVIGNON, J
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1982, 9 (02) : 191 - 194
  • [7] EFFECTS OF PROBUCOL ON PLASMA-LIPOPROTEIN SUBFRACTIONS AND ACTIVITIES OF LIPOPROTEIN-LIPASE AND HEPATIC TRIGLYCERIDE LIPASE
    HOMMA, Y
    MORIGUCHI, EH
    SAKANE, H
    OZAWA, H
    NAKAMURA, H
    GOTO, Y
    ATHEROSCLEROSIS, 1991, 88 (2-3) : 175 - 181
  • [8] POST-HEPARIN PLASMA-LIPOPROTEIN LIPASE IN FAMILIAL HYPERALPHALIPOPROTEINEMIA - RELATIONSHIPS WITH HDL CHOLESTEROL
    TASKINEM, MR
    HYND, B
    ROBINSON, K
    GLUECK, CJ
    CIRCULATION, 1979, 60 (04) : 72 - 72
  • [9] EFFECT OF CYCLOSPORINE ON PLASMA-LIPOPROTEIN LIPASE ACTIVITY IN RATS
    LOPEZMIRANDA, J
    PEREZJIMENEZ, F
    GOMEZGERIQUE, JA
    ESPINOMONTORO, A
    HIDALGOROJAS, L
    PEDRENO, J
    JIMENEZPEREPEREZ, JA
    CLINICAL BIOCHEMISTRY, 1992, 25 (05) : 387 - 394
  • [10] THE EFFECT OF APOLIPOPROTEINS IN MODULATING PLASMA-LIPOPROTEIN LIPASE ACTIVITY
    WANG, CS
    KLOER, HU
    MCCONATHY, WJ
    ALAUPOVIC, P
    ARTERIOSCLEROSIS, 1983, 3 (05): : A496 - A496